drugset / Trial / NCT00479479

Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development

NCT00479479

RandomizedParallel-groupOpen-labelBasic science

Summary

Adequate levels of vitamin B12 (cobalamin) is necessary for normal growth and development in infants. We have earlier investigated cobalamin status in healthy children and we observed metabolic evidence of impaired cobalamin status during the first 6 months, but not later in life. The purpose of this study is to determine if cobalamin supplementation may influence the metabolic profile related to cobalamin status in infants.

Timeline

Start
2004-12
Primary completion
2006-08
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxocobalamin Unknown 400 ug Intramuscular